The Impact of Primary Tumor Volume on Survival of Patients with Non-Surgically Treated Advanced-Stage Hypopharyngeal Cancer- Retrospective Study and Literature Overview

被引：0

作者：

Jakovljevic, Sasa ^{[1
,2
]}

Djordjevic, Vladimir ^{[1
,2
]}

Tomanovic, Nada ^{[1
,3
]}

Arsovic, Nenad ^{[1
,2
]}

Dudvarski, Zoran ^{[1
,2
]}

Ursulovic, Tamara ^{[4
]}

Laketic, Darko ^{[1
,5
]}

Jovanovic, Katarina ^{[2
]}

Arsovic, Konstantin ^{[2
]}

Radivojevic, Nemanja ^{[1
,2
]}

机构：

[1] Univ Belgrade, Fac Med, Belgrade 11000, Serbia

[2] Univ Clin Ctr Serbia, Clin Otorhinolaryngol & Maxillofacial Surg, Belgrade, Serbia

[3] Inst Pathol, Belgrade, Serbia

[4] Inst Oncol & Radiol Serbia, Belgrade, Serbia

[5] Inst Anat, Belgrade, Serbia

来源：

INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY | 2025年 / 77卷 / 01期

关键词：

Advanced hypopharyngeal cancer; Cancer prognosis; Non-surgical treatment; Tumor volume; Survival; SQUAMOUS-CELL CARCINOMA; ADVANCED HEAD; NECK-CANCER; LARYNX CANCER; PROGNOSTIC-FACTORS; LOCAL-CONTROL; RADIOCHEMOTHERAPY; CHEMORADIATION; PRESERVATION; RADIOTHERAPY;

D O I：

10.1007/s12070-024-05139-z

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

To determine the prognostic value of tumor volume in predicting the survival in patients with stage III-IV of hypopharyngeal carcinoma. We studied 71 patients with advanced stage of hypopharyngeal carcinoma. The volume of primary tumor was calculated by approximation of the ellipsoid volume. Correlation between carcinoma volume and demographic, clinical and carcinoma characteristics has shown that male patients and patients consuming alcohol had greater tumor volumes. The median of overall survival was at 12 months (95% CI: 9.25-14.75); the median of progression-free survival was at 9 months (95% CI: 6.6-11.3). ROC Curve Analysis of carcinoma volumes in outcome prediction shows that the cutoff of 14.69 had the sensitivity of 61% and specifics of 89%. Based on significant independent impact of tumor volume on survival, it is important to include this parameter among possible new treatment protocols.

引用

页码：184 / 193

页数：10

共 22 条

[11] Prognostic factors predicting survival in incurable stage IV colorectal cancer patients who underwent palliative primary tumor resection. Retrospective cohort study
Kim, Min Sung
Park, Eun Jung
Kang, Jeonghyun
Min, Byung Soh
Lee, Kang Young
Kim, Nam Kyu
Baik, Seung Hyuk
INTERNATIONAL JOURNAL OF SURGERY, 2018, 49 : 10 - 15
[12] Predicting personalised and progressive adaptive dose escalation to gross tumour volume using knowledge-based planning models for inoperable advanced-stage non-small cell lung cancer patients treated with volumetric modulated arc therapy
Tambe, Nilesh S.
Pires, Isabel M.
Moore, Craig
Wieczorek, Andrew
Upadhyay, Sunil
Beavis, Andrew W.
BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 2022, 8 (03)
[13] Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
Lin, Shu-Yung
Yang, Ching-Yao
Liao, Bin-Chi
Ho, Chao-Chi
Liao, Wei-Yu
Chen, Kuan-Yu
Tsai, Tzu-Hsiu
Hsu, Chia-Lin
Hsu, Wei-Hsun
Su, Kang-Yi
Chang, Yih-Leong
Lee, Jih-Hsiang
Lin, Chia-Chi
Shih, Jin-Yuan
Yang, James Chih-Hsin
Yu, Chong-Jen
JOURNAL OF CANCER, 2018, 9 (10): : 1813 - 1820
[14] Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase-rearranged Advanced Non-Small Cell Lung Cancer Patients Treated With Crizotinib
Hida, Tomoyuki
Dahlberg, Suzanne E.
Lydon, Christine A.
Hatabu, Hiroto
Johnson, Bruce E.
Awad, Mark M.
Nishino, Mizuki
JOURNAL OF THORACIC IMAGING, 2020, 35 (02) : 101 - 107
[15] A Pilot Study of Texture Analysis of Primary Tumor [18F]FDG Uptake to Predict Recurrence in Surgically Treated Patients with Non-small Cell Lung Cancer
Nakajo, Masatoyo
Jinguji, Megumi
Shinaji, Tetsuya
Aoki, Masaya
Tani, Atsushi
Nakabeppu, Yoshiaki
Nakajo, Masayuki
Sato, Masami
Yoshiura, Takashi
MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (04) : 771 - 780
[16] Tumor Volume Decrease at 8 Weeks Is Associated with Longer Survival in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Patients Treated with EGFR TKI
Nishino, Mizuki
Dahlberg, Suzanne E.
Cardarella, Stephanie
Jackman, David M.
Rabin, Michael S.
Hatabu, Hiroto
Jaenne, Pasi A.
Johnson, Bruce E.
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (08) : 1059 - 1068
[17] Effects of primary tumor resection on the survival of patients with stage IV extrathoracic metastatic non-small cell lung cancer: A population-based study
Sun, Zewen
Sui, Xizhao
Yang, Fan
Wang, Jun
LUNG CANCER, 2019, 129 : 98 - 106
[18] The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)
Ball, David L.
Fisher, Richard J.
Burmeister, Bryan H.
Poulsen, Michael G.
Graham, Peter H.
Penniment, Michael G.
Vinod, Shalini K.
Krawitz, Hedley E.
Joseph, David J.
Wheeler, Greg C.
McClure, Bev E.
RADIOTHERAPY AND ONCOLOGY, 2013, 106 (03) : 305 - 311
[19] Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study
Yang, Xiongwen
Xiao, Yi
Zhou, Yubin
Deng, Huiyin
Yuan, Zihao
Dong, Longyan
Lan, Jun
Hu, Hao
Huang, Jian
Huang, Shaohong
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[20] Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy
Dehing-Oberije, Cary
De Ruysscher, Dirk
van der Weide, Hiska
Hochstenbag, Monique
Bootsma, Gerben
Geraedts, Wiel
Pitz, Cordula
Simons, Jean
Teule, Jaap
Rahmy, Ali
Thimister, Paul
Steck, Harald
Lambin, Philippe
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 1039 - 1044

← 1 2 3 →